|
|
Article: Rhone-Poulenc Rorer Announces Major Expansion of Manufacturing in Singapore
- Article from:
- PR Newswire
- Article date:
- May 12, 1997
CopyrightCOPYRIGHT 1997 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Plant to Manufacture World's Best-Selling Low Molecular Weight Heparin
/Editors: This press release was issued earlier in Australia./
COLLEGEVILLE, Pa., and SINGAPORE, May 12 /PRNewswire/ -- Rhone-Poulenc Rorer Inc. (NYSE: RPR) announced today that it will invest $50 million USD ($75 million Singapore dollars) to build a new chemical manufacturing plant for the production of enoxaparin sodium, the active ingredient in Lovenox(R)/Clexane(R) Injection.
Lovenox/Clexane is a low-molecular-weight heparin used in the prevention of deep-vein thrombosis following hip and knee surgery and is the world's leading low-molecular-weight heparin ...